US Patent 9249226 Antibodies against human CD38
Patent 9249226 was granted and assigned to Genmab A/S on February, 2016 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 8, 2011
Date of Patent
February 2, 2016
Patent Application Number
13702857
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9249226 Antibodies against human CD38
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.